Imv Inc Expected to Post Q1 2020 Earnings of ($0.13) Per Share (TSE:IMV)

Share on StockTwits

Imv Inc (TSE:IMV) – Research analysts at Oppenheimer issued their Q1 2020 EPS estimates for shares of IMV in a research report issued on Monday, December 9th. Oppenheimer analyst J. Olson expects that the company will post earnings per share of ($0.13) for the quarter. Oppenheimer has a “Outperform” rating and a $9.00 price target on the stock. Oppenheimer also issued estimates for IMV’s Q2 2020 earnings at ($0.12) EPS, Q3 2020 earnings at ($0.16) EPS and Q4 2020 earnings at ($0.11) EPS.

IMV (TSE:IMV) last issued its earnings results on Friday, November 8th. The company reported C($0.16) earnings per share for the quarter, missing the consensus estimate of C($0.12) by C($0.04). The firm had revenue of C$0.16 million for the quarter, compared to analyst estimates of C$0.06 million.

Shares of IMV stock opened at C$3.85 on Thursday. The company has a debt-to-equity ratio of 66.56, a quick ratio of 3.87 and a current ratio of 4.47. The firm’s 50-day simple moving average is C$3.49 and its 200-day simple moving average is C$3.88. IMV has a twelve month low of C$2.77 and a twelve month high of C$7.75. The firm has a market cap of $189.87 million and a P/E ratio of -6.99.

About IMV

IMV Inc, a clinical-stage immuno-oncology company, together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer. The company's DPX drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.

Featured Story: Preferred Stock

Earnings History and Estimates for IMV (TSE:IMV)

Receive News & Ratings for IMV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMV and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Arrowhead Pharmaceuticals Inc  Shares Acquired by Nisa Investment Advisors LLC
Arrowhead Pharmaceuticals Inc Shares Acquired by Nisa Investment Advisors LLC
Nisa Investment Advisors LLC Sells 18,900 Shares of Waddell & Reed Financial, Inc.
Nisa Investment Advisors LLC Sells 18,900 Shares of Waddell & Reed Financial, Inc.
Nisa Investment Advisors LLC Increases Holdings in Unitil Co.
Nisa Investment Advisors LLC Increases Holdings in Unitil Co.
Nisa Investment Advisors LLC Grows Position in Generac Holdings Inc.
Nisa Investment Advisors LLC Grows Position in Generac Holdings Inc.
Nisa Investment Advisors LLC Lowers Stock Holdings in Easterly Government Properties Inc
Nisa Investment Advisors LLC Lowers Stock Holdings in Easterly Government Properties Inc
Nisa Investment Advisors LLC Buys 300 Shares of Horizon Therapeutics PLC
Nisa Investment Advisors LLC Buys 300 Shares of Horizon Therapeutics PLC


© 2006-2020 Ticker Report